Sermorelin 5mg

Sermorelin corresponds to the biologically active 1-29 amino-acid fragment of endogenous growth hormone-releasing hormone (GHRH), studied in GH-axis receptor-pharmacology research.

Sermorelin research characterizes GHRH-receptor binding and downstream cAMP/PKA signaling in pituitary somatotrope cell models, serving as a reference compound for comparing longer-acting GHRH analogs.

• CJC + Ipamorelin 5/5mg — a related compound frequently studied alongside Sermorelin in comparative research designs.

For in-vitro assay preparation, researchers calculate a target concentration (mg/mL) from the vial's labeled mass and the volume of sterile diluent added, then aliquot and store per standard laboratory cold-chain practice. This is a laboratory dilution calculation only, performed strictly for analytical or in-vitro research purposes. Not for use in humans or animals.

Lyophilized powder should be stored at -20°C for long-term stability, or refrigerated (2-8°C) for short-term use, protected from light and moisture. Once reconstituted for laboratory use, follow standard cold-chain handling and use within the timeframe indicated by your institution's protocols.

Sermorelin ships with a QR-linked, batch-specific certificate of analysis (COA) confirming identity and purity via HPLC. Researchers should always confirm the lot number on their vial matches the COA on file before beginning any assay.

This reference material is manufactured and quality-tested to support reproducible research outcomes. Every batch is independently verified before it ships, and COAs remain accessible for future reference.